Latest filing published 17 Dec 2019 for Spark Therapeutics, Inc., €5.2M.
Joseph La Barge appears in our data through filings on Spark Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 19 May 2016 to 17 December 2019, the count stands at 54 filings.
No open-market purchase appears, only 20 sales worth €2.6M. Outside the open market, there are 7 share grants and 25 option exercises.
The latest filing, published on 17 December 2019, reports a transaction of €5.2M in Spark Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 54 declarations